Selected article for: "cov induce and lung damage"
Author: Veras, F. P.; Pontelli, M.; Silva, C.; Toller-Kawahisa, J.; de Lima, M.; Nascimento, D.; Schneider, A.; Caetite, D.; Rosales, R.; Colon, D.; Martins, R.; Castro, I.; Almeida, G.; Lopes, M. I.; Benatti, M.; Bonjorno, L.; Giannini, M.; Luppino-Assad, R.; Almeida, S.; Vilar, F.; Santana, R.; Bollela, V.; Martins, M.; Miranda, C.; Borges, M.; Pazin-Filho, A.; Cunha, L.; Zamboni, D.; Dal-Pizzol, F.; Leiria, L.; Siyuan, L.; Batah, S.; Fabro, A.; Mauad, T.; Dolhnikoff, M.; Duarte-Neto, A.; Saldiva, P.; Cunha, T.; Alves-Filho, J. C.; Arruda, E.; Louzada-Junior, P.; Oliveira, R.; Cunha, F.
Title: SARS-CoV-2 triggered neutrophil extracellular traps (NETs) mediate COVID-19 pathology
  • Cord-id: w9a8tsg6
  • Document date: 2020_6_9
    • ID: w9a8tsg6
    Snippet: Severe COVID-19 patients develop acute respiratory distress syndrome that may progress to respiratory failure. These patients also develop cytokine storm syndrome, and organ dysfunctions, which is a clinical picture that resembles sepsis. Considering that neutrophil extracellular traps (NETs) have been described as an important factors of tissue damage in sepsis, we investigated whether NETs would be produced in COVID-19 patients and participate in the lung tissue damage. A cohort of 32 hospital
    Document: Severe COVID-19 patients develop acute respiratory distress syndrome that may progress to respiratory failure. These patients also develop cytokine storm syndrome, and organ dysfunctions, which is a clinical picture that resembles sepsis. Considering that neutrophil extracellular traps (NETs) have been described as an important factors of tissue damage in sepsis, we investigated whether NETs would be produced in COVID-19 patients and participate in the lung tissue damage. A cohort of 32 hospitalized patients with a confirmed diagnosis of COVID-19 and respective healthy controls were enrolled. NETs concentration was assessed by MPO-DNA PicoGreen assay or by confocal immunofluorescence. The cytotoxic effect of SARS-CoV-2-induced NETs was analyzed in human epithelial lung cells (A549 cells). The concentration of NETs was augmented in plasma and tracheal aspirate from COVID-19 patients and their neutrophils spontaneously released higher levels of NETs. NETs were also found in the lung tissue specimens from autopsies of COVID-19 patients. Notably, viable SARS-CoV-2 can directly induce in vitro release of NETs by healthy neutrophils in a PAD-4-dependent manner. Finally, NETs released by SARS-CoV-2-activated neutrophils promote lung epithelial cell death in vitro. These results unravel a possible detrimental role of NETs in the pathophysiology of COVID-19. Therefore, the inhibition of NETs represent a potential therapeutic target for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • activate neutrophil and acute lung injury: 1
    • activated neutrophil and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
    • activated neutrophil and acute lung injury: 1, 2, 3, 4, 5
    • activated neutrophil and lung damage: 1
    • activated neutrophil and lung epithelial cell: 1
    • activated neutrophil and lung epithelial cell apoptosis: 1
    • activated neutrophil and lung epithelial cell damage: 1
    • active viral infection and acute lung injury: 1
    • active viral infection and lung damage: 1
    • acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung endothelial epithelial cell: 1, 2, 3
    • acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and lung epithelial cell damage: 1, 2
    • acute ards respiratory distress syndrome and lung epithelial cell death: 1
    • acute ards respiratory distress syndrome develop and lung damage: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome develop and lung endothelial epithelial cell: 1
    • acute ards respiratory distress syndrome develop and lung epithelial cell: 1
    • acute ards respiratory distress syndrome develop and lung epithelial cell damage: 1
    • acute lung injury and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25